Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 2/2015

01-02-2015 | Review Article

Ayurvedic interventions for osteoarthritis: a systematic review and meta-analysis

Authors: Christian S. Kessler, Lea Pinders, Andreas Michalsen, Holger Cramer

Published in: Rheumatology International | Issue 2/2015

Login to get access

Abstract

Ayurveda is one of the fastest growing systems within complementary and alternative medicine. However, the evidence for its effectiveness is unsatisfactory. The aim of this work was to review and meta-analyze the effectiveness and safety of different Ayurvedic interventions in patients with osteoarthritis (OA). 138 electronic databases were searched through August 2013. Randomized controlled trials, randomized crossover studies, cluster-randomized trials, and non-randomized controlled clinical trials were eligible. Adults with pre-diagnosed OA were included as participants. Interventions were included as Ayurvedic if they were explicitly labeled as such. Main outcome measures were pain, physical function, and global improvement. Risk of bias was assessed using the Cochrane risk of bias tool. 19 randomized and 14 non-randomized controlled trials on 12 different drugs and 3 non-pharmaceutical interventions with a total of 2,952 patients were included. For the compound preparation, Rumalaya, large and apparently unbiased effects beyond placebo were found for pain (standardized mean difference [SMD] −3.73; 95 % confidence interval [CI] −4.97, −2.50; P < 0.01) and global improvement (risk ratio 12.20; 95 % CI 5.83, 25.54; P < 0.01). There is also some evidence that effects of the herbal compound preparation Shunti-Guduchi are comparable to those of glucosamine for pain (SMD 0.08; 95 % CI −0.20, 0.36; P = 0.56) and function (SMD 0.15; 95 % CI −0.12, 0.36; P = 0.41). Based on single trials, positive effects were found for the compound preparations RA-11, Reosto, and Siriraj Wattana. For Boswellia serrata, Lepidium Sativum, a Boswellia serrata containing multicomponent formulation and the compounds Nirgundi Taila, Panchatikta Ghrita Guggulu, and Rhumayog, and for non-pharmacological interventions like Ayurvedic massage, steam therapy, and enema, no evidence for significant effects against potential methodological bias was found. No severe adverse events were observed in all trials. The drugs Rumalaya and Shunti-Guduchi seem to be safe and effective drugs for treatment of OA-patients, based on these data. However, several limitations relate to clinical research on Ayurveda. Well-planned, well-conducted and well-published trials are warranted to improve the evidence for Ayurvedic interventions.
Literature
1.
2.
Denoeud L, Mazieres B, Payen-Champenois C, Ravaud P (2005) First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence. Ann Rheum Dis 64(1):70–74PubMedCrossRefPubMedCentral
3.
Fernandes L, Hagen KB, Bijlsma JW, Andreassen O, Christensen P, Conaghan PG, Doherty M, Geenen R, Hammond A, Kjeken I, Lohmander LS, Lund H, Mallen CD, Nava T, Oliver S, Pavelka K, Pitsillidou I, da Silva JA, de la Torre J, Zanoli G, Vliet Vlieland TP (2013) EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 72(7):1125–1135PubMedCrossRef
4.
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64(4):465–474CrossRef
5.
Larmer PJ, Reay ND, Aubert ER, Kersten P (2014) Systematic review of guidelines for the physical management of osteoarthritis. Arch Phys Med Rehabil 95(2):375–389PubMedCrossRef
6.
Tramer MR, Moore RA, Reynolds DJ, McQuay HJ (2000) Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain 85(1–2):169–182PubMedCrossRef
7.
Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA (2007) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115(12):1634–1642PubMedCrossRef
8.
Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332(7553):1302–1308PubMedCrossRefPubMedCentral
9.
Dieppe P, Marsden D (2013) Managing arthritis: the need to think about whole systems. Rheumatology (Oxford) 52(8):1345–1346CrossRef
10.
11.
Jadhav PM, Jadhav MP (2013) Complementary and alternative medicine and conventional medicine: hand in hand. J Clin Rheumatol 19(4):227PubMedCrossRef
12.
Morandi A, Tosto C, Roberti di Sarsina P, Dalla Libera D (2011) Salutogenesis and Ayurveda: indications for public health management. EPMA J 2(4):459–465PubMedCrossRefPubMedCentral
13.
14.
Kessler C, Michalsen A (2012) The role of whole medical systems in global medicine. Forsch Komplementmed 19(2):65–66PubMedCrossRef
15.
World Health Organization (2002) Traditional Medicine Strategy. WHO Regional Publications, Geneva
16.
World Health Organization (2002) Traditional Medicine in Asia. WHO Regional Publications, New Delhi
17.
18.
19.
World Health Organization (2010) Benchmarks for training in traditional/complementary and alternative medicine: Benchmarks for training in Ayurveda. World Health Organization, Geneva
20.
Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B (2013) Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 52(8):1408–1417CrossRef
21.
Furst DE, Venkatraman MM, Krishna Swamy BG, McGann M, Booth-Laforce C, Ram Manohar P, Sarin R, Mahapatra A, Krishna Kumar PR (2011) Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis. Ann Rheum Dis 70(2):392–393PubMedCrossRef
22.
Furst DE, Venkatraman MM, McGann M, Manohar PR, Booth-LaForce C, Sarin R, Sekar PG, Raveendran KG, Mahapatra A, Gopinath J, Kumar PR (2011) Double-blind, randomized, controlled, pilot study comparing classic Ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis. J Clin Rheumatol 17(4):185–192PubMedCrossRef
23.
Witt CM, Michalsen A, Roll S, Morandi A, Gupta S, Rosenberg M, Kronpass L, Stapelfeldt E, Hissar S, Muller M, Kessler C (2013) Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee–study protocol for a randomized controlled trial. Trials 14:149PubMedCrossRefPubMedCentral
24.
25.
26.
Agarwal V, Abhijnhan A, Raviraj P (2007) Ayurvedic medicine for schizophrenia. Cochrane Database Syst Rev 4:CD006867PubMed
27.
Hardy ML, Coulter I, Venuturupalli S, Roth EA, Favreau J, Morton SC, Shekelle P (2001) Ayurvedic interventions for diabetes mellitus: a systematic review. Evid Rep Technol Assess (Summ) 41:2p
28.
Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Norman Scholfield C (2014) Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol 151(1):528–535PubMedCrossRef
29.
Park J, Ernst E (2005) Ayurvedic medicine for rheumatoid arthritis: a systematic review. Semin Arthritis Rheum 34(5):705–713PubMedCrossRef
30.
Shekelle PG, Hardy M, Morton SC, Coulter I, Venuturupalli S, Favreau J, Hilton LK (2005) Are Ayurvedic herbs for diabetes effective? J Fam Pract 54(10):876–886PubMed
31.
Singh BB, Khorsan R, Vinjamury SP, Der-Martirosian C, Kizhakkeveettil A, Anderson TM (2007) Herbal treatments of asthma: a systematic review. J Asthma 44(9):685–698PubMedCrossRef
32.
Singh BB, Vinjamury SP, Der-Martirosian C, Kubik E, Mishra LC, Shepard NP, Singh VJ, Meier M, Madhu SG (2007) Ayurvedic and collateral herbal treatments for hyperlipidemia: a systematic review of randomized controlled trials and quasi-experimental designs. Altern Ther Health Med 13(4):22–28PubMed
33.
Sridharan K, Mohan R, Ramaratnam S, Panneerselvam D (2011) Ayurvedic treatments for diabetes mellitus. Cochrane Database Syst Rev 12:CD008288PubMed
34.
Dash B, Sharma R (2001) Caraka Samhita: Text with English Translation and Critical Exposition based o Cakrapani Datta’s Ayurveda Dipika. Chaukhamba Sanskrit Series Office, New Delhi
35.
Gupta S, Stapelfeld E (2009) Praxis Ayurveda-Medizin. Kaya cikitsa. Therapiekonzepte für innere Erkrankungen. Haug, Stuttgart
36.
Morandi A, Tosto C (2011) Ayurveda, the paradigm for personalized medicine. EPMA J 2:S152–S153CrossRef
37.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29(8):1039–1049PubMedCrossRef
38.
Belo JN, Berger MY, Koes BW, Bierma-Zeinstra SM (2009) The prognostic value of the clinical ACR classification criteria of knee osteoarthritis for persisting knee complaints and increase of disability in general practice. Osteoarthritis Cartilage 17(10):1288–1292PubMedCrossRef
39.
Feuerstein G (1998) The yoga tradition. Hohm Press, Prescott
40.
Cramer H, Lauche R, Langhorst J, Dobos G (2013) Yoga for rheumatic diseases: a systematic review. Rheumatology (Oxford) 52(11):2025–2030CrossRef
41.
Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M (1997) Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 24(4):799–802PubMed
42.
Pham T, Van Der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V, Woodworth T, Dougados M (2003) Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol 30(7):1648–1654PubMed
43.
Juhl C, Lund H, Roos EM, Zhang W, Christensen R (2012) A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. Arthritis 2012:136245PubMedCrossRefPubMedCentral
44.
45.
Babu S, Shetty M (2005) Yoga Ratnakara (Sanskrit Text with English Translation and Explanatory Notes). Chaukhamba Sanskrit Series Office, Varanasi
46.
Murthy S (1998) Bhava Prakasha (Translation). Chaukhamba Orientalia, Varanasi
47.
Murthy SK (2001) Madhava Nidanam (Roga Viniscaya) of Mahavakara (A Treatise on Ayurveda). Chaukambha Orientala, Varanasi
48.
Higgins J, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley, West SussexCrossRef
49.
50.
The Nordic Cochrane Centre (2013) Review Manager 5 software (Version 5.1), Copenhagen
51.
52.
Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK, Bichile L, Narsimulu G, Handa R, Patwardhan B (2011) A randomized controlled exploratory evaluation of standardized Ayurvedic formulations in symptomatic osteoarthritis knees: a Government of India NMITLI project. Evid Based Complement Alternat Med 2011:724291PubMedCrossRefPubMedCentral
53.
Rastogi S, Sivaraman ST (2003) Evaluating the safety and efficacy of Rumalaya forte: a double-blind clinical trial. Orthopaedics Today 5(1):63–65
54.
Singh U, Kishore K, Seth S (1997) Comparative clinical study of indigenous drug with Ibuprofen in patients of osteoarthritis. Indian J Phys Med Rehabil (IJPMR) 8–9(April):29–30
55.
Srivastava KC, Mustafa T (1992) Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 39(4):342–348PubMedCrossRef
56.
Kimmatkar N, Thawani V, Hingorani L, Khiyani R (2003) Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomedicine 10(1):3–7PubMedCrossRef
57.
Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP (2008) A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther 10(4):R85PubMedCrossRefPubMedCentral
58.
Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri SP (2010) Comparative efficacy and tolerability of 5-Loxin and Aflapin against osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci 7(6):366–377PubMedCrossRefPubMedCentral
59.
Gupta I, Gupta S, Parihar A (1993) S-compound: a traditional drug for osteoarthritis patients. Indian Practitioner 46(1):69–72
60.
Gupta PK, Samarakoon SM, Chandola HM, Ravishankar B (2011) Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis). Ayu 32(4):478–482PubMedCrossRefPubMedCentral
61.
Sontakke S, Thawani V, Pimpalkhute S, Kabra P, Babhulkar S, Hingorani L (2007) Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian J Pharmacol 39(1):27CrossRef
62.
Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B (1991) Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33(1–2):91–95PubMedCrossRef
63.
Raval ND, Pandya TN (2009) Clinical Trial of Lepidium Sativum Linn (Chandrashura) in the Management of Sandhivata (Osteoarthritis). AYU (An international quarterly journal of research in Ayurveda) 30(2):153
64.
Das B, Padhi MM, Singh OP, Deep VC, Tewari NS, Panda N (2003) Clinical evaluation of nirgundi taila in the management of sandhivata. Anc Sci Life 23(1):22–34PubMedPubMedCentral
65.
Akhtar B, Mahto RR, Dave AR, Shukla VD (2010) Clinical study on Sandhigata Vata w.s.r. to Osteoarthritis and its management by Panchatikta Ghrita Guggulu. Ayu 31(1):53–57PubMedCrossRefPubMedCentral
66.
Sharma A, Sharma R, Mohite K (2003) Management of Sandhigata vata (OA) with Shamana and Shodhana therapy—a Pilot study. J Res Ayurveda Siddha CCRAS XXIV: 1–2
67.
Chopra A, Lavin P, Patwardhan B, Chitre D (2004) A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 10(5):236–245PubMedCrossRef
68.
Nachinolcar UC, Prasad DP, Prasad SR, Mitra SK (2007) Rumalaya forte and Reosto in Osteoarthritis: a combined study. Med Update 15(4):27–35
69.
Agarwal ND, Gureja Y, Khosla AC, Agarwal JR (1971) Rumalaya in rheumatoid arthritis and osteo arthritis (a double-blind trial). Probe 10:45–49
70.
Chandanwale AS, Kulkarni KS (2003) Clinical evaluation of Rumalaya forte in osteoarthrosis. Med Update 10:23–26
71.
Khare KD, Khare R, Kolhapure SA (2004) Evaluation of the efficacy and safety of JT-2000* in Osteoarthritis: a randomized controlled clinical trial. Indian J Clin Pract 14(10):42–47
72.
Jamdar J, Singh K, Kulhalli P, Chakma T (2004) Study of ayurvedic drug (rhumayog) compared to brufen in osteoarthritis. Antiseptic 101(2):62–65
73.
Singh U, Kishore K, Seth S (1997) Comparative clinical study of indigenous drug with Ibuprofen in patients of osteoarthritis. Indian J Phys Med Rehabil (IJPMR) 8–9(April):29–30
74.
Srivastava N, Sadh R, Jain B, Kolhapure S (2005) Evaluation and comparative clinical efficacy and safety of Rumalaya forte in patients suffering from osteoarthritis of the knee. Indian J Clin Prac 16:19–30
75.
Upadhyay L, Tripathi K (2004) Clinical evaluation of the efficacy of JT-2000 (Rumalaya forte) in the management of osteoarthritis: a double-blind placebo-controlled trial. Med Update 11(10):31
76.
Mathur HH, Khurana A, Mathur DD, Kolhapure SA (2004) Evaluation of the efficacy and safety of JT-2000 in osteoarthritis: a comparative clinical trial. Med Update 11(9):31–37
77.
Sandhu HS, Kaler JS (1978) Rumalaya therapy in rheumatoid arthritis, osteoarthritis and periarthritis shoulder. Antisep 10:63–66
78.
Sen B, Banerjee S, Mazumder N, Sarkar N, Roychowdury A, Majumdar P (1980) Studies on effects of Rumalaya in osteoarthritis. Indian Med J 74:151
79.
Taneja DK, Chara GU (1975) Rumalaya in osteoarthritis. Antisep 72(10):527–533
80.
Jamdar J, Singh K, Kulhalli P, Chakma T (2004) Study of ayurvedic drug (rhumayog) compared to brufen in osteoarthritis. Antisep 101(2):62–65
81.
Chopra A, Manjit S, Tillu G, Venugopalan A, Narsimulu G, Sarmukaddam S, Patwardhan B (2012) Evaluating higher doses of Shunti-Guduchi formulations for safety in osteoarthritis knees: a government of India NMITLI arthritis project. J Ayurveda Integr Med 3(1):38–44PubMedCrossRefPubMedCentral
82.
Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B (2013) Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 52(8):1408–1417CrossRef
83.
Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK, Bichile L, Narsimulu G, Handa R, Patwardhan B (2011) A randomized controlled exploratory evaluation of standardized Ayurvedic formulations in symptomatic osteoarthritis knees: a Government of India NMITLI Project. Evid Based Complement Alternat Med 2011:724291PubMedCrossRefPubMedCentral
84.
Joshi A, Mehta CS, Dave AR, Shukla VD (2011) Clinical effect of Nirgundi Patra pinda sweda and Ashwagandhadi Guggulu Yoga in the management of Sandhigata Vata (Osteoarthritis). Ayu 32(2):207–212PubMedCrossRefPubMedCentral
85.
Pathak B, Dwivedi KK, Shukla KP (1992) Clinical evaluation of snehana Swedana and an Ayurvedic compound drug in sandhivata vis-a-vis osteoarthritis. JREIM 11(2):27–34
86.
Rajoria K, Singh SK, Sharma RS, Sharma SN (2010) Clinical study on Laksha Guggulu, Snehana, Swedana & Traction in Osteoarthritis (Knee joint). Ayu 31(1):80–87PubMedCrossRefPubMedCentral
87.
Prameshwa KA, SK T (2002) Comparative study of therapeutic efficacy of Samshodana and Samshamana Chikitsa in Sadhigatavata vis-a-vis osteo arthritis. JRAS 24(1–2):21–32
88.
Shah M, Shukla V, Dave A, Bhatt N (2010) A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis). Ayu 31(2):210–217PubMedCrossRefPubMedCentral
89.
Nuesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, Egger M, Juni P (2010) Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 341:c3515PubMedCrossRefPubMedCentral
90.
Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2010) OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 18(4):476–499PubMedCrossRef
91.
Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM (2013) A systematic review of recommendations and guidelines for the management of osteoarthritis: The Chronic Osteoarthritis Management Initiative of the U.S. Bone and Joint Initiative. Semin Arthritis Rheum
92.
Kessler C (2007) Wirksamkeit von Ayurveda bei chronischen Erkrankungen. Systematische Analysen klinischer Ayurveda-Studien. KVC Verlag, Essen
93.
Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152(11):726–732PubMedCrossRef
94.
Kales SN, Christophi CA, Saper RB (2007) Hematopoietic toxicity from lead-containing Ayurvedic medications. Med Sci Monit 13(7):CR295–CR298PubMedPubMedCentral
95.
Kales SN, Saper RB (2009) Ayurvedic lead poisoning: an under-recognized, international problem. Indian J Med Sci 63(9):379–381PubMedCrossRef
96.
Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, Phillips RS (2004) Heavy metal content of ayurvedic herbal medicine products. JAMA 292(23):2868–2873PubMedCrossRef
97.
Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, Paquin J, Thuppil V, Kales SN (2008) Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA 300(8):915–923PubMedCrossRefPubMedCentral
98.
Raviraja A, Vishal Babu GN, Sehgal A, Saper RB, Jayawardene I, Amarasiriwardena CJ, Venkatesh T (2010) Three cases of lead toxicity associated with consumption of ayurvedic medicines. Indian J Clin Biochem 25(3):326–329PubMedCrossRefPubMedCentral
Metadata
Title
Ayurvedic interventions for osteoarthritis: a systematic review and meta-analysis
Authors
Christian S. Kessler
Lea Pinders
Andreas Michalsen
Holger Cramer
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2015
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3095-y

Other articles of this Issue 2/2015

Rheumatology International 2/2015 Go to the issue

Short Communication

Abdominal aortic aneurysm causing lumbar vertebral erosion in Behçet’s disease presenting by low back pain

Original Article

Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial

Original Article

Are occupational repetitive movements of the upper arm associated with rotator cuff calcific tendinopathies?

Letter to the Editor

Pneumococcal arthroentesitis and multiple myeloma

Original Article - Safety / Pharmacovigillance

Perioperative use of anti-rheumatic agents does not increase early postoperative infection risks: a Veteran Affairs’ administrative database study

Letter to the Editor - Replies

Re: “Abdominal aortic aneurysm causing lumbar vertebral erosion in Behcet’s disease presenting by low back pain”

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits